Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
26.67 M
About Syros Pharmaceuticals, Inc.
Sector
Industry
Website
Headquarters
Cambridge
Founded
2011
FIGI
BBG00JVXHG98
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0LC7 is 0.0270 USD — it has increased by 11.11% in the past 24 hours. Watch SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) stocks are traded under the ticker 0LC7.
0LC7 stock has risen by 21.08% compared to the previous week, the month change is a 8.00% rise, over the last year SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) has showed a −99.45% decrease.
0LC7 reached its all-time high on Jan 20, 2021 with the price of 151.9000 USD, and its all-time low was 0.0162 USD and was reached on Apr 4, 2025. View more price dynamics on 0LC7 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0LC7 stock is 10.80% volatile and has beta coefficient of 2.45. Track SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) there?
Yes, you can track SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
No, 0LC7 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0LC7 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) stock shows the sell signal. See more of SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.